Pre-order Enquiry
Request Free Sample
Global Inflammatory Bowel Disease (IBD) Therapeutics Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application
SKU ID : QYR-14118525 | Publishing Date : 19-Apr-2019 | No. of pages : 92
Detailed TOC of Global Inflammatory Bowel Disease (IBD) Therapeutics Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application
Table of ContentsInflammatory Bowel Disease (IBD) Therapeutics Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025
1 Industry Overview of Inflammatory Bowel Disease (IBD) Therapeutics
1.1 Inflammatory Bowel Disease (IBD) Therapeutics Market Overview
1.1.1 Inflammatory Bowel Disease (IBD) Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size and Analysis by Regions
1.2.1 North America
1.2.2 Europe
1.2.3 China
1.2.4 Rest of Asia Pacific
1.2.5 Central & South America
1.2.6 Middle East & Africa
1.3 Inflammatory Bowel Disease (IBD) Therapeutics Market by Type
1.3.1 Anti-inflammatory Biologics
1.3.2 Non-Steroidal Anti-inflammatory drugs (NSAIDs)
1.3.3 Corticosteroids
1.4 Inflammatory Bowel Disease (IBD) Therapeutics Market by End Users/Application
1.4.1 Hospital
1.4.2 Research
2 Global Inflammatory Bowel Disease (IBD) Therapeutics Competition Analysis by Players
2.1 Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Value) by Players (2018 and 2019)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Abbvie
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Inflammatory Bowel Disease (IBD) Therapeutics Revenue (Value) (2014-2019)
3.1.5 Recent Developments
3.2 Johnson & Johnson
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Inflammatory Bowel Disease (IBD) Therapeutics Revenue (Value) (2014-2019)
3.2.5 Recent Developments
3.3 GlaxoSmithKline
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Inflammatory Bowel Disease (IBD) Therapeutics Revenue (Value) (2014-2019)
3.3.5 Recent Developments
3.4 Merck
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Inflammatory Bowel Disease (IBD) Therapeutics Revenue (Value) (2014-2019)
3.4.5 Recent Developments
3.5 Novartis
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Inflammatory Bowel Disease (IBD) Therapeutics Revenue (Value) (2014-2019)
3.5.5 Recent Developments
3.6 Celgene
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Inflammatory Bowel Disease (IBD) Therapeutics Revenue (Value) (2014-2019)
3.6.5 Recent Developments
3.7 Pfizer
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Inflammatory Bowel Disease (IBD) Therapeutics Revenue (Value) (2014-2019)
3.7.5 Recent Developments
3.8 Salix
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Inflammatory Bowel Disease (IBD) Therapeutics Revenue (Value) (2014-2019)
3.8.5 Recent Developments
3.9 Roche
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Inflammatory Bowel Disease (IBD) Therapeutics Revenue (Value) (2014-2019)
3.9.5 Recent Developments
3.10 Teva Pharmaceutical
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Inflammatory Bowel Disease (IBD) Therapeutics Revenue (Value) (2014-2019)
3.10.5 Recent Developments
4 Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Type and Application (2014-2019)
4.1 Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Type (2014-2019)
4.2 Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Application (2014-2019)
4.3 Potential Application of Inflammatory Bowel Disease (IBD) Therapeutics in Future
4.4 Top Consumer/End Users of Inflammatory Bowel Disease (IBD) Therapeutics
5 North America Inflammatory Bowel Disease (IBD) Therapeutics Development Status and Outlook
5.1 North America Inflammatory Bowel Disease (IBD) Therapeutics Market Size (2014-2019)
5.2 North America Inflammatory Bowel Disease (IBD) Therapeutics Market Size and Market Share by Players (2018 and 2019)
6 Europe Inflammatory Bowel Disease (IBD) Therapeutics Development Status and Outlook
6.1 Europe Inflammatory Bowel Disease (IBD) Therapeutics Market Size (2014-2019)
6.2 Europe Inflammatory Bowel Disease (IBD) Therapeutics Market Size and Market Share by Players (2018 and 2019)
7 China Inflammatory Bowel Disease (IBD) Therapeutics Development Status and Outlook
7.1 China Inflammatory Bowel Disease (IBD) Therapeutics Market Size (2014-2019)
7.2 China Inflammatory Bowel Disease (IBD) Therapeutics Market Size and Market Share by Players (2018 and 2019)
8 Rest of Asia Pacific Inflammatory Bowel Disease (IBD) Therapeutics Development Status and Outlook
8.1 Rest of Asia Pacific Inflammatory Bowel Disease (IBD) Therapeutics Market Size (2014-2019)
8.2 Rest of Asia Pacific Inflammatory Bowel Disease (IBD) Therapeutics Market Size and Market Share by Players (2018 and 2019)
9 Central & South America Inflammatory Bowel Disease (IBD) Therapeutics Development Status and Outlook
9.1 Central & South America Inflammatory Bowel Disease (IBD) Therapeutics Market Size (2014-2019)
9.2 Central & South America Inflammatory Bowel Disease (IBD) Therapeutics Market Size and Market Share by Players (2018 and 2019)
10 Middle East & Africa Inflammatory Bowel Disease (IBD) Therapeutics Development Status and Outlook
10.1 Middle East & Africa Inflammatory Bowel Disease (IBD) Therapeutics Market Size (2014-2019)
10.2 Middle East & Africa Inflammatory Bowel Disease (IBD) Therapeutics Market Size and Market Share by Players (2018 and 2019)
11 Market Forecast by Regions, Type and Application (2019-2025)
11.1 Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Value) by Regions (2019-2025)
11.1.1 North America Inflammatory Bowel Disease (IBD) Therapeutics Revenue and Growth Rate (2019-2025)
11.1.2 Europe Inflammatory Bowel Disease (IBD) Therapeutics Revenue and Growth Rate (2019-2025)
11.1.3 China Inflammatory Bowel Disease (IBD) Therapeutics Revenue and Growth Rate (2019-2025)
11.1.4 Rest of Asia Pacific Inflammatory Bowel Disease (IBD) Therapeutics Revenue and Growth Rate (2019-2025)
11.1.5 Central & South America Inflammatory Bowel Disease (IBD) Therapeutics Revenue and Growth Rate (2019-2025)
11.1.6 Middle East & Africa Inflammatory Bowel Disease (IBD) Therapeutics Revenue and Growth Rate (2019-2025)
11.2 Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Value) by Type (2019-2025)
11.3 Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size by Application (2019-2025)
12 Inflammatory Bowel Disease (IBD) Therapeutics Market Dynamics
12.1 Inflammatory Bowel Disease (IBD) Therapeutics Market Opportunities
12.2 Inflammatory Bowel Disease (IBD) Therapeutics Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Inflammatory Bowel Disease (IBD) Therapeutics Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Inflammatory Bowel Disease (IBD) Therapeutics Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
List of Figures, Tables and Charts Available in Global Inflammatory Bowel Disease (IBD) Therapeutics Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application
List of Tables and FiguresFigure Inflammatory Bowel Disease (IBD) Therapeutics Product Scope
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) (2014-2019)
Table Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Share by Regions in 2018
Figure North America Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Europe Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure China Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Rest of Asia Pacific Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Central & South America Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Middle East & Africa Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Share by Type in 2018
Figure Anti-inflammatory Biologics Market Size (Million USD) and Growth Rate (2014-2019)
Figure Non-Steroidal Anti-inflammatory drugs (NSAIDs) Market Size (Million USD) and Growth Rate (2014-2019)
Figure Corticosteroids Market Size (Million USD) and Growth Rate (2014-2019)
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Share by Application in 2018
Table Key Downstream Customer in Hospital
Figure Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) and Growth Rate in Hospital (2014-2019)
Table Key Downstream Customer in Research
Figure Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) and Growth Rate in Research (2014-2019)
Table Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) by Players (2018 and 2019)
Figure Inflammatory Bowel Disease (IBD) Therapeutics Market Size Share by Players in 2018
Figure Inflammatory Bowel Disease (IBD) Therapeutics Market Size Share by Players in 2019
Table Abbvie Basic Information List
Table Inflammatory Bowel Disease (IBD) Therapeutics Business Revenue (Million USD) of Abbvie (2014-2019)
Figure Abbvie Inflammatory Bowel Disease (IBD) Therapeutics Business Revenue Market Share in 2018
Table Johnson & Johnson Basic Information List
Table Inflammatory Bowel Disease (IBD) Therapeutics Business Revenue (Million USD) of Johnson & Johnson (2014-2019)
Figure Johnson & Johnson Inflammatory Bowel Disease (IBD) Therapeutics Business Revenue Market Share in 2018
Table GlaxoSmithKline Basic Information List
Table Inflammatory Bowel Disease (IBD) Therapeutics Business Revenue (Million USD) of GlaxoSmithKline (2014-2019)
Figure GlaxoSmithKline Inflammatory Bowel Disease (IBD) Therapeutics Business Revenue Market Share in 2018
Table Merck Basic Information List
Table Inflammatory Bowel Disease (IBD) Therapeutics Business Revenue (Million USD) of Merck (2014-2019)
Figure Merck Inflammatory Bowel Disease (IBD) Therapeutics Business Revenue Market Share in 2018
Table Novartis Basic Information List
Table Inflammatory Bowel Disease (IBD) Therapeutics Business Revenue (Million USD) of Novartis (2014-2019)
Figure Novartis Inflammatory Bowel Disease (IBD) Therapeutics Business Revenue Market Share in 2018
Table Celgene Basic Information List
Table Inflammatory Bowel Disease (IBD) Therapeutics Business Revenue (Million USD) of Celgene (2014-2019)
Figure Celgene Inflammatory Bowel Disease (IBD) Therapeutics Business Revenue Market Share in 2018
Table Pfizer Basic Information List
Table Inflammatory Bowel Disease (IBD) Therapeutics Business Revenue (Million USD) of Pfizer (2014-2019)
Figure Pfizer Inflammatory Bowel Disease (IBD) Therapeutics Business Revenue Market Share in 2018
Table Salix Basic Information List
Table Inflammatory Bowel Disease (IBD) Therapeutics Business Revenue (Million USD) of Salix (2014-2019)
Figure Salix Inflammatory Bowel Disease (IBD) Therapeutics Business Revenue Market Share in 2018
Table Roche Basic Information List
Table Inflammatory Bowel Disease (IBD) Therapeutics Business Revenue (Million USD) of Roche (2014-2019)
Figure Roche Inflammatory Bowel Disease (IBD) Therapeutics Business Revenue Market Share in 20187
Table Teva Pharmaceutical Basic Information List
Table Inflammatory Bowel Disease (IBD) Therapeutics Business Revenue (Million USD) of Teva Pharmaceutical (2014-2019)
Figure Teva Pharmaceutical Inflammatory Bowel Disease (IBD) Therapeutics Business Revenue Market Share in 2018
Table Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) by Type (2014-2019)
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size Share by Type in 2014
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size Share by Type in 2015
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size Share by Type in 2016
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size Share by Type in 2017
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size Share by Type in 2018
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size Share by Type in 2019
Table Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) by Application (2014-2019)
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) by Application in 2014
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) by Application in 2015
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) by Application in 2015
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) by Application in 2017
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) by Application in 2018
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) by Application in 2019
Table Top Consumer/End Users of Inflammatory Bowel Disease (IBD) Therapeutics
Figure North America Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table North America Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure North America Inflammatory Bowel Disease (IBD) Therapeutics Market Size Share by Players in 2018
Figure North America Inflammatory Bowel Disease (IBD) Therapeutics Market Size Share by Players in 2019
Figure Europe Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table Europe Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure Europe Inflammatory Bowel Disease (IBD) Therapeutics Market Size Share by Players in 2018
Figure Europe Inflammatory Bowel Disease (IBD) Therapeutics Market Size Share by Players in 2019
Figure China Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table China Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure China Inflammatory Bowel Disease (IBD) Therapeutics Market Size Share by Players in 2018
Figure China Inflammatory Bowel Disease (IBD) Therapeutics Market Size Share by Players in 2019
Figure Rest of Asia Pacific Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table Rest of Asia Pacific Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure Rest of Asia Pacific Inflammatory Bowel Disease (IBD) Therapeutics Market Size Share by Players in 2018
Figure Rest of Asia Pacific Inflammatory Bowel Disease (IBD) Therapeutics Market Size Share by Players in 2019
Figure Central & South America Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table Central & South America Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure Central & South America Inflammatory Bowel Disease (IBD) Therapeutics Market Size Share by Players in 2018
Figure Central & South America Inflammatory Bowel Disease (IBD) Therapeutics Market Size Share by Players in 2019
Figure Middle East & Africa Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table Middle East & Africa Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure Middle East & Africa Inflammatory Bowel Disease (IBD) Therapeutics Market Size Share by Players in 2018
Figure Middle East & Africa Inflammatory Bowel Disease (IBD) Therapeutics Market Size Share by Players in 2019
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) by Regions (2019-2025)
Table Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) by Regions (2019-2025)
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size Share by Regions in 2019
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size Share by Regions in 2025
Figure North America Inflammatory Bowel Disease (IBD) Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Europe Inflammatory Bowel Disease (IBD) Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure China Inflammatory Bowel Disease (IBD) Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Rest of Asia Pacific Inflammatory Bowel Disease (IBD) Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Central & South America Inflammatory Bowel Disease (IBD) Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Middle East & Africa Inflammatory Bowel Disease (IBD) Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Table Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) by Type (2019-2025)
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size Share by Type in 2019
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size Share by Type in 2025
Table Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) by Application (2019-2025)
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) by Application in 2019
Figure Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size (Million USD) by Application in 2025
Keyplayers in Global Inflammatory Bowel Disease (IBD) Therapeutics Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application
AbbvieJohnson & Johnson
GlaxoSmithKline
Merck
Novartis
Celgene
Pfizer
Salix
Roche
Teva Pharmaceutical
Request Sample
Request Discount
